The aortic heart valve opens and closes ≈3 billion times in a person's lifetime, making it arguably one of the most mechanically demanding environments in the body ( Figure 1A ). The valve has 3 leaflets or cusps of thin tissue composed of collagen, elastin, and glycosaminoglycans 1 and is striated into 3 layers ( Figure 1B) . Vascularization of the valve is not necessary because the cusps are thin enough for oxygen, nutrients, and waste to diffuse between the tissue and the surrounding blood. 
and impart structural integrity to the valve ( Figure 1C) . 1 In the ventricularis layer, adjacent to the left ventricle, elastin fibers are aligned radially to provide flexibility during valve opening and to aid in leaflet recoil. 3 Glycosaminoglycans dominate the middle spongiosa lubricating layer, allowing the outer layers to slide easily over one another during leaflet motion. 2, 4, 5 The variations in the composition and distribution of matrix components in each layer of the valve lead to measurable layer-specific variations in mechanical properties. Stella and Sacks 6 characterized aortic valve layer elasticities via microdissection and biaxial mechanical testing. They found that the collagen-rich fibrosa, the elastin-rich ventricularis, and the glycosaminoglycan-rich spongiosa made up 41%, 29%, and 30% of the whole aortic valve tissue, respectively. This work also demonstrated that most of the structural integrity of the aortic valve is supplied by the fibrosa because the intact valve and separated fibrosa both displayed abrupt increases in tension with small loads when tested biaxially, whereas the ventricularis exhibited a compliant equibiaxial behavior. These studies suggest that the collagen-rich fibrosa and the elastin-rich ventricularis have different elasticities. Vesely and Noseworthy 7 also found layer-specific elasticities by uniaxial tensile testing of microdissected layers, with the fibrosa being stiffer than the ventricularis (13 versus 7.4 kPa, respectively, in the circumferential direction).
Separation of the leaflet layers may influence their mechanical behavior, so others have measured layer-specific properties of intact leaflets. By flexural testing of intact leaflets, Sacks and coworkers confirmed that the fibrosa is stiffer than the ventricularis. 8, 9 The Simmons research group measured the unloaded moduli of the fibrosa and ventricularis of intact porcine aortic valve tissue using a micropipette aspiration method. Consistent with others, they found that the effective modulus of the fibrosa, based on a hyperelastic exponential constitutive model, was significantly greater than that of the ventricularis; when translated to elastic moduli at low strain, the average fibrosa and ventricularis moduli were 8.4 and 5.6 kPa, respectively. 11 Of note, focal regions in the fibrosa were as stiff as 21 kPa, a stiffness never reached in any region of the ventricularis. SewellLoftin et al 12 used atomic force microscopy nanoindentation to measure the unloaded moduli of the 3 layers of 10-μm-thick porcine aortic valve cryosections. Although they also found the fibrosa to be the stiffest of the 3 layers, they obtained much higher moduli than those measured by tensile testing of microdissected layers or micropipette aspiration of intact leaflets: The fibrosa was ≈2 MPa; the ventricularis was just over 1 MPa; and the spongiosa was ≈0.6 MPa.
The broad range of reported moduli is attributable to differences in testing methods, including putative artifacts introduced by tissue dissection/sectioning and differences in applied stress ranges; differences in constitutive models used to interpret test data; and differences in the parameters used to define a single modulus value for a nonlinearly elastic material (eg, the selection of the applied stress level at which the modulus is determined). Nonetheless, these studies all suggest that the collagen-rich fibrosa layer provides the majority of the structural support in the aortic valve. The discrepancies between studies, all performed to date on normal aortic valves, underscore the need to reconcile the methods used to spatially map mechanical properties of the valve tissue and especially as a function of disease progression.
Aortic Valve Cells
The aortic valve tissue architecture is synthesized and maintained by the resident valvular interstitial cells (VICs). 2, 5 In the healthy adult valve, VICs are largely a quiescent fibroblast phenotype, with a minor (<5%) population of myofibroblasts and smooth muscle cells. [13] [14] [15] [16] [17] During development, on valve injury, and with disease, VICs can be activated to a secretory myofibroblast phenotype. 18 A potent activator of the VICs to the myofibroblast phenotype is transforming growth factor-β1 (TGF-β1), [18] [19] [20] [21] [22] [23] an inflammatory cytokine that is present in diseased valves. 24 The hallmark indicator for an activated myofibroblast is α-smooth muscle actin (αSMA) stress fibers within the cytoskeleton. 25 Activated VICs perform many functions to promote valve repair and homeostasis, including proliferation 18, 21, 26 and secretion of cytokines such as TGF-β1, 19 matrix metalloproteinases, 18, 19, 21, 27 and ECM molecules. 18, 21, 22, 27, 28 In addition to myofibroblasts, diseased valves contain osteoblast-like cells and other ectopic mesenchymal cells [29] [30] [31] ; these cells are likely derived primarily from resident mesenchymal progenitor cells, 32 although endothelialto-mesenchymal transformation 33 and circulating progenitor cells 34, 35 may also contribute. VIC phenotype and function are regulated by cues from their local environment, including paracrine signaling molecules (eg, endothelium-derived signals as discussed below), inflammatory cytokines (eg, TGF-β1), 19 the biochemical and biomechanical properties of their ECM, 11, 22, 23, [36] [37] [38] [39] [40] and mechanical stimuli induced by hemodynamic forces (eg, normal or pathological stretching of the valve tissue). [41] [42] [43] [44] [45] In addition, there appear to be interactions, and sometimes synergies, between each of these types of cues, with the mechanical environment playing a critical modulatory role. For example, increases in the transvalvular pressure gradient (TPG) lead to higher levels of valve tissue stretching, 46 likely resulting in mechanical activation of latent TGF-β1, 20 which in turn can potentiate VIC activation to the myofibroblast phenotype. 19, 44 Because activated myofibroblasts secrete TGF-β1 themselves in response to mechanical stimulation, it is evident how this signaling pathway may spiral out of control to promote disease if not correctly regulated. The role of hemodynamic forces and their interaction with other microenvironmental signals in regulating VIC phenotype are discussed further below.
Beyond cells residing in the bulk tissue matrix, aortic valve leaflets are lined with a monolayer of valvular endothelial cells (VlvECs). VlvECs, much like the endothelial lining of the vasculature, serve as a protective lining for the underlying tissue by regulating permeability, mediating inflammation, and preventing thrombrosis. 47, 48 Although there are many similarities between vascular and valvular endothelial cells (ECs) in these functions, interesting and important differences exist. Transcriptional profiling of porcine aortic vascular versus aortic valve ECs demonstrated significant differences between the 2 cell types in vitro. 49 Of the 847 genes studied, 55 genes were expressed at similar levels in both EC types, but 48 genes were expressed by only 1 cell type or the other. Genes that were common to both cell types included those related to paracrine signaling molecules such as latent TGF-β1, bone morphogenetic protein (BMP) -7 and -9, and fibroblast growth factor-3, the cytoskeletal protein β-actin, and the cell-cell interaction protein cadherin-11. Genes that were expressed only by vascular ECs included those for the paracrine signaling protein vascular endothelial growth factor-B and the cell-cell interaction protein vascular cell adhesion molecule-1, whereas only VlvECs expressed connective tissue growth factor and T-cell chemoattractant interleukin-16, genes associated with paracrine signaling proteins.
Functional similarities and differences between VlvECs and vascular ECs also exist. For example, VlvECs are more permeable than the ECs of major arteries, 50 with focal regions of high and low permeability 50, 51 that may be responsible for focal lesion development during early stages of disease. 52 Similar to vascular disease, valvular disease is associated with inflammation, including systemic endothelial dysfunction 53 and increased expression of vascular cell adhesion molecule-1, intercellular adhesion molecule-1, and E-selectin by VlvECs. 54, 55 It is notable, however, that VlvECs in disease-prone regions of porcine aortic valves demonstrate anti-inflammatory and antioxidative transcriptional profiles, 56 even when challenged with a short-term hypercholesterolemic diet, 52 perhaps as acute protection against a systemic propathological insult. VlvECs regulate coagulation similar to vascular ECs through the expression of nitric oxide (NO), 57 prostacyclin, 58, 59 von Willebrand factor, 60 and tissue factor. 61 In contrast to the vasculature, however, high blood flow-induced shear stresses rarely cause thrombosis of the aortic valve, 62 suggesting differing abilities in vascular versus valvular ECs to resist denudation and coagulation under high shear stress. 47 These differences may be explained, in part, by differential adhesion strengths to different ECM proteins. 63 In addition to their barrier function, VlvECs are believed to play a critical role in regulating VIC phenotype locally via paracrine signaling. For example, VlvECs have been shown to regulate the mechanical stiffness of aortic valves ex vivo, likely through paracrine regulation of VIC contractile state by NO. 64 Homeostasis and focal disease development also may be influenced by VlvEC-derived paracrine signals that inhibit pathological differentiation of VICs locally. 56, 65, 66 However, EC secretion of vasoactive substances such as NO, 67 and other paracrine molecules is shear stress regulated, and thus, proper function of the VlvECs seems to be critically linked to the hemodynamic characteristics of the aortic valve environment.
Clinical Identification of Aortic Stenosis
In the clinic, aortic stenosis (AS) is usually identified via echocardiography or catheter analysis for the effective orifice area (EOA), blood velocity (v), and TPG. 1, 68 However, there is still debate as to the best method of detection of AS to avoid incorrect diagnosis and the best time for replacement of the stenotic valve. A severely stenotic aortic valve has an EOA of <1 cm 2 and a blood velocity of >4 m/s, 68 whereas a normal valve has a blood velocity of ≈1.35 m/s. 41, 69 TPG can be calculated using the maximum blood velocity and the following equation,
, which is a simplified version of the pressure/ velocity relationship derived from the Bernoulli equation. 68 As this equation suggests, TPG increases quadratically with increases in blood velocity, which is directly affected by the EOA of the aortic valve. 68, 70, 71 One complicating factor in correctly diagnosing and treating AS is simultaneous hypertension, which occurs in 35% to 45% of patients with AS. 68 Elevated blood pressure levels can decrease the TPG measured with conventional methods (eg, echocardiography), making it difficult to detect the onset of AS. The levels of blood velocity, vorticity (ie, eddies), and TPG all combine to influence the deformation of valvular tissue during systole and diastole, and current research is still striving to elucidate how these hemodynamic aspects influence the onset of disease progression toward AS.
Hemodynamic Effects on Aortic Valve Tissue
Attempts aimed at understanding the hemodynamic aspects of valve disease in the literature have been sparse until the past decade. The first appearance of modeling blood flow and valve leaflet motion in the literature appeared in 1977, when Hung and Schuessler 72 developed the first multidimensional computational model of the aortic valve. This work demonstrated a basic understanding of how the valve opens during systole ( Figure 2A ). However, the modeling method required major simplifying assumptions such as neglecting blood vorticities (eg, eddies), which are important for aortic valve function.
With advances in computer modeling capabilities, more accurate modeling of blood flow through the aortic valve could be achieved. Garcia et al 73 were able to model the TPG using a more accurate, expanded Bernoulli equation,
and l are the static pressure, velocity, fluid density, and curvilinear coordinate along the streamline, respectively, and neglecting any gravity contribution. These values were compared with values obtained through standard clinical measures such as Doppler echocardiography with fairly good accuracy. 73 As demonstrated in Figure 2B , the authors predicted the TPG for several different EOA in the severe (0.5 cm 2 ) to moderate (1.65 cm 2 ) AS range as a function of time (ie, over the course of 1 heart cycle) and overlaid them with measured values. They also confirmed that the error between their predicted TPG values compared with experimentally measured values for TPG >50 mm Hg was <10%.
A more recent example of modeling aortic valve function in normal and malformed aortic valves (ie, tricuspid versus bicuspid) used finite-element structural analysis to compute the stress and strain distribution on the leaflets. 74 Bicuspid valves were achieved by fusing 2 leaflets of an excised tricuspid valve, indicated by the red line ( Figure 2C ). Jermihov et al 74 first demonstrated that they could achieve stress/strain curves in the circumferential and radial directions for healthy aortic valve tissue similar to those measured experimentally. Once their model and assumptions were verified, they modeled the maximum in-plane stress at the instant that the valve is closed (ie, diastole). They found that the geometry of the leaflets had a higher impact on the stress than did small modulations in the mechanical properties of the valve tissue ( Figure 2C ). This suggests that increases in valve tissue stiffness may not cause significant increases in the TPG, and therefore, the contribution of other factors may likely dominate. The insight gained from this work and future directions in this area should aid in a better understanding of the acceleration of disease progression in malformed aortic valves and suggest opportunities for their treatment and prevention.
Complementary to the computational studies modeling blood flow through the aortic valve, the Yoganathan group used particle image velocimetry tracking in conjunction with porcine valve explants to study the flow of blood through malformed bicuspid and normal tricuspid valves. 71 They found that the smaller EOAs of bicuspid valves lead to a significant increase in fluid velocity, vorticity, TPG, and ventricular side shear stresses compared with normal tricuspid valves ( Figure 2D ). However, some amount of each of these hemodynamic features seems to be critical in proper valve function. For example, the normal tricuspid valve requires some amount of vorticity to facilitate rapid valve closure after systole. 71 Using a similar particle tracking and aortic valve explantation technique, Yap et al 75, 76 were also able to demonstrate that the shear stresses on the ventricular side of the valve are higher than those on the aortic side. The ventricular side shear stress peaked at 64 to 71 dynes/cm 2 during systole and reversed in direction at the end of systole for only 15 to 25 milliseconds at 40 to 51 dynes/cm 2 . In contrast, peak shear stresses on the aortic side were estimated to be <20 dynes/cm 2 . They also compared their valve explant experimental results with shear stresses calculated for in vivo measurements using their theoretical model and found that they were similar (ie, 77-92 dynes/cm 2 on the ventricular side). In addition, Yap et al 77 found that hypertension increases the stretch of the valve tissue in both the radial and circumferential directions. Severe hypertension caused an even higher degree of valve stretch. Collectively, these studies suggest a possible link between blood flow and the properties of aortic valve tissue, where alterations to one may also affect the other.
Hemodynamic Effects on Aortic Valve Cells
The hemodynamic aspects of blood flow impart important cues to the vascular system (ie, vascular ECs). These cues can be mechanical or biochemical and are critical in directing proper function of not only the vasculature system but also the surrounding tissues. For example, conditions associated with valve disease such as hypertension-related tachycardia can lead to reduced levels of aortic side shear stress, 76 which has been implicated in changes in VlvEC gene expression, function, and viability. 78, 79 Hypertensive hemodynamic conditions can also increase the stretch of the vasculature system, which can lead to increased fibrosis of surrounding tissue. 80, 81 Although these studies of the vascular ECs give us some insight into how VlvECs might behave, current research has highlighted several key differences that warrant study of VlvECs specifically and their relationship with aortic VICs.
Hemodynamic Effects on Aortic Valvular ECs
Blood flow-induced shear stress is an important stimulus for VlvEC function and the contributions of VlvECs to valve development, homeostasis, and disease. Shear stress sensitivity of ECs is evident in many ways, most obviously in their change in morphology. In the vasculature, ECs elongate and align parallel to the direction of blood flow in vivo, [82] [83] [84] except in regions of disturbed flow such as bifurcations where ECs are polygonal and rounded. 85 Although this is also the case in the developing aortic valve, 86 there are regions of postnatal valves where VlvEC elongation is perpendicular to flow, likely because of contact guidance cues from underlying, circumferentially oriented collagen fibrils. 87 Interestingly, actin stress fibers in VlvECs follow flow direction, regardless of cell shape. 88 Porcine aortic VlvECs were initially reported to align perpendicular to the direction of flow in vitro. 79 However, recent results indicate that human aortic VlvECs 89 and pure populations of postconfluent porcine VlvECs (S. Srigunapalan, BASc, E.W.K. Young, PhD, and C.A. Simmons, PhD, unpublished data, 2008) align parallel to the direction of flow in vitro. Differences between the first and subsequent studies may be a result of cell type, the purity of the VlvEC population, cell density, and the ECM on which the cells were grown. 91 Thus, although there is good evidence that VlvECs are phenotypically different from vascular ECs, alignment to flow now appears not to be a general distinguishing feature.
The sensitivity of VlvECs to specific hemodynamic environments may be responsible for significant differences in gene expression by VlvECs located on opposite sides of the aortic valve leaflets. Simmons et al 56 were the first to demonstrate that VlvECs were phenotypically different on the aortic versus ventricular side of normal, noninflamed porcine aortic valves. Transcriptional profiles suggested that the diseaseprone aortic surface is permissive to fibrosis and calcification but protected by an enhanced antioxidative state. In pigs fed a high-cholesterol diet for 2 weeks to induce early aortic valve disease, there was an unexpected induction and persistence of a protective endothelial phenotype on the pathosusceptible aortic side. 52 miRNA-370, which is upregulated during the endothelial-to-mesenchymal transdifferentiation, is also expressed in a side-dependent manner, with higher expression on the ventricular side of human aortic valves. 89 Shear stress studies in vitro suggest that side-dependent VlvEC phenotypes are, at least in part, hemodynamically regulated because there is partial correspondence in differential gene expression between fibrosa versus ventricularis VlvECs 56 and VlvECs subjected to static versus 20 dynes/cm 2 unidirectional steady shear stress in vitro. 43, 90 Of relevance to valve disease, oxidative and inflammatory gene expression patterns were suppressed with undisturbed shear stress in vitro, as was expression of chondrogenic genes putatively involved in osteochondral ossification. 43 Consistent with this observation, leaflets exposed to altered shear stress ex vivo demonstrate increased expression of the inflammatory proteins vascular cell adhesion molecule-1, intercellular adhesion molecule-1, BMP-4, and TGF-β1, but only on the aortic side, indicating side-dependent shear sensitivity that correlates with side-dependent disease susceptibility. 78 A likely mechanism by which shear stress contributes to valve homeostasis and disease development is its regulation of VlvEC paracrine signaling to VICs. Butcher and Nerem 43 demonstrated this in vitro by culturing VICs and VlvECs in 3-dimensional type I collagen hydrogels and found the most significant reduction in VIC expression of the myofibroblast marker αSMA when VlvECs were present and subjected to shear stress. NO may be responsible for shear-dependent VlvEC regulation of VIC activation because endothelial NO synthase mRNA is modestly upregulated by shear stress in VlvECs 80 and the NO donors diethylenetriamine-NONOate and sodium nitroprusside prevent the formation of VIC contraction-induced calcific nodules in vitro. 65 NO expression can also be reduced by other factors such as hypercholesterolemia or diabetes mellitus. 91 Another intriguing candidate for shear stress-dependent VlvEC paracrine regulation of VIC phenotype is C-type natriuretic peptide (CNP), which elicits similar responses to NO via its induction of cGMP. 92 CNP is expressed in the normal aortic valve, with higher expression in ventricular side VlvECs, 56 consistent with it being a shear-sensitive protein. 93 In culture, CNP prevents VICs from differentiating to the myofibroblasts and osteoblast lineages, suggesting that it plays a homeostatic role in the aortic valve. 94 Indeed, CNP expression is distinctly downregulated in stenotic human valves. 95 The implications from these studies are 2-fold. First, when the aortic valve leaflet shear stress environment is pathologically altered, EC function may suffer. Healthy endothelium is essentially a gatekeeper for molecular diffusion and cell penetration into the tissue interstitial space and bloodstream. 96 However, when pathological blood flow exposes the endothelium to disturbed, low-shear-stress flow on the aortic side, endothelial dysfunction can occur, leading to inflammation, enhanced permeability of small molecules through the EC barrier, and potentially apoptosis of the ECs (Figure 3) . 1, 77, 97, 98 The increase in endothelial permeability results in nonspecific regulation of the diffusion of molecules into the tissue such as inflammatory cytokines 97 that may lead to propagation of the myofibroblast phenotype of VICs and disease progression. In addition, EC apoptosis would reduce expression and diffusion of protective paracrine signaling molecules (eg, NO and CNP), which results in less regulation of the activated myofibroblast phenotype. 1 Second, even under normal physiological flow conditions, paracrine factors expressed in a shear-dependent manner on 1 side of the leaflet may contribute to locally protect or promote pathological development. 66 In the case of CNP, its higher expression in ventricular side VlvECs may protect the ventricularis, whereas the lack of expression on the aortic side may leave the fibrosa vulnerable to lesion formation. Similar examples include the following: BMP-4, a proinflammatory and pro-osteogenic chemokine that is expressed at higher levels on the disease-prone aortic side in normal pig aortic valves, 56, 99 the BMP antagonists chordin, 56 noggin, CV-2/BMP-binding endothelial regulator, the BMP inhibitor Smad-6, 100 and osteoprotegerin, a putative inhibitor of calcification. 56 All these factors are deficient on the disease-prone aortic side of porcine and human aortic valves.
Hemodynamic Effects on Aortic VICs
The hemodynamic forces applied to valve leaflets cause bending, tensile, and compressive forces in the tissue, which are ultimately transduced to the embedded VICs through their adhesions to the ECM. Although VICs are likely somewhat shielded from large macroscale tissue deformations, as in other connective tissues, the adaptation of VIC phenotypes to the dynamic mechanical changes that occur during development and in engineered tissues 101 clearly demonstrates that hemodynamic forces can regulate VIC function in vivo.
Aortic valve tissue stretch (or strain) occurs during diastole when the TPG across the leaflet from the left ventricle to the aorta causes the leaflet to lengthen in the circumferential and radial directions. 102 Increases in TPG, as occurs with hypertension, increase the amount of stretch experienced by valve tissue. 6 Owing to the organization of the aortic valve ECM, leaflet tissue is mechanically anisotropic, exhibiting greater compliance in the radial direction than in the circumferential direction ( Figure 4A and 4B) . 41 Anisotropic stretch of valve leaflets not only influences valve function but also may influence VIC mechanobiological responses. 103 The tension generated in the leaflet during diastole causes the VICs to stretch. 104 Sacks et al 104 demonstrated that VIC nuclear deformation, as a surrogate measure for cell strain, increases with increasing TPG and tissue stretch. Notably, VICs in the fibrosa layer deformed more than those in the ventricularis; differential VIC deformation, and the functional consequences thereof, may explain, in part, why myofibroblast activation and lesion formation occur most frequently in the fibrosa. 66 Figure 5 illustrates how healthy and diseased hemodynamic conditions may influence stretching VIC and their nuclei.
Multiple ex vivo and in vitro studies have demonstrated that pathological stretch of valve tissue or isolated VICs can elicit responses associated with valve disease development, most notably increased matrix synthesis and remodeling 45, [105] [106] [107] and VIC activation to the secretory myofibroblast phenotype. 44, 45, 106, 108 These findings have potentially provocative implications linking pathological stretch with the deterioration in aortic valve tissue properties and function that occurs with disease. Indeed, Thayer et al 45 found that subjecting aortic valve leaflets to a combination of pathological stretch and pressure loads ex vivo caused a significant increase in the thickness of the fibrosa and spongiosa layers ( Figure 4C ).
Because myriad different types of microenvironmental cues regulate VIC phenotype, mechanical forces interact with and modulate the effects of other stimuli to influence VIC function. For example, Merryman et al 44 found a synergistic effect of valve tissue stretching and TGF-β1 treatment on VIC myofibroblast differentiation. They reported that after 14 days in culture, VIC αSMA expression was similar when valve leaflets were cyclically stretched in tension or cultured statically with soluble TGF-β1. However, when both tension and TGF-β1 were applied to the valve leaflets simultaneously, αSMA expression increased synergistically. Moraes et al 108 also observed interaction between stretching and TGF-β1 treatment in the activation of isolated VICs but found that synergism depended on the layer from which the VICs were isolated (ie, fibrosa versus ventricularis) and the ECM protein on which they were cultured. The link between mechanical stimulation and TGF-β1 signaling was further supported by subsequent research that implicated cell-mediated mechanical activation of latent TGF-β1. Specifically, Wipff and Hinz 20 found that the latent (ie, inactive) form of TGF-β1, which is sequestered by various ECM molecules, is mechanically activated by cells. This process is facilitated by an integrin-binding RGD sequence that is present on the latent TGF-β1 protective shell to which cells can bind and contract to release the active form of TGF-β1. It is reasonable to believe that this phenomenon may occur in valve tissue subjected to dynamic mechanical stimulation because stretching of the valve tissue causes VIC elongation. In addition, activated myofibroblastic VICs are able to secrete their own TGF-β1 in the latent form. 18, 19 Secreted TGF-β1 can be sequestered by the surrounding ECM and subsequently mechanically activated, putatively leading to the synergistic effects of tissue tension and TGF-β1 treatment observed by Merryman et al. 44 Once the TGF-β1 is activated, it is able to diffuse freely through the tissue until it binds with its cell surface receptor. Mechanical deformation of the valve tissue through tensile stretching and bending most likely increases the diffusion of molecules such as TGF-β1 through the valve tissue, thereby propagating its effects remotely to influence neighboring VICs.
The Role of Valve Matrix in Hemodynamic Regulation of Valve Cells
Deformation of valve leaflet tissue as a result of hemodynamic forces is transferred to valve cells through their adhesion to the ECM. Thus, valve cell responses to external mechanical forces are regulated, in part, by the mechanical and adhesive properties of the ECM. As discussed above, VlvEC and VIC responses to pathological mechanical forces and biochemical stimuli often result in dysregulated ECM remodeling by myofibroblasts that degrade and disrupt normal tissue components and replace them with disorganized rigid collagens and bone. 4, 5, 30, 109 As the composition of the aortic valve tissue is exchanged from the normal trilaminar structure containing elastin, glycosaminoglycans, and collagen to the diseased jumble of various collagens and bone, the function of the aortic valve is compromised. With stiffer components, the valve leaflets are less flexible, which decreases the EOA and consequently increases the TPG, blood velocity, vorticity, and shear stress that in turn feed back to further promote valve cell pathological behavior, all of which ultimately exacerbate the onset of aortic stenosis.
Although the influence of the mechanical properties of valve tissue on valve hemodynamic function and the resultant external forces applied to valve cells is clear, matrix elasticity likely also modulates valve cell biology directly. The reason is that adherent cells apply tractional forces to their matrix, which are resisted in part by the inherent elasticity of the ECM. 110 VIC traction likely periodically stiffens the aortic valve tissue during the unloaded state of systole ( Figure 5 , right), 8, 41 but even in tissues that are dynamically deformed by external forces, cytoskeletal prestress induced by tractional forces often exceeds external stresses applied to cells. 111 Because cells respond to changes in matrix elasticity by altering their adhesion to the ECM and cytoskeletal organization, the mechanical and biochemical properties of the matrix can activate and modify intracellular signaling pathways and cell responses and functions.
Matrix Elasticity Effects on VIC Function
Substrate elasticity has been shown in vitro to regulate pathological behavior in VICs, specifically myofibroblast differentiation and calcific nodule formation. Benton et al 23 saw a significant increase in the number of calcific nodules formed via VIC contraction on tissue culture-treated polystyrene (TCPS) compared with VICs seeded on poly(ethylene glycol) hydrogels functionalized with the integrin-binding small peptide RGD, which had essentially no nodule formation. Rapid calcified nodule formation on stiff substrates is indicative of VIC myofibroblast differentiation and contraction, leading to apoptosis and dystrophic calcification. 40 Consistent with the findings from Benton et al, 23 Pho et al 39 found that single VICs did not robustly differentiate into myofibroblasts on soft, thick, fibrillar type I collagen gels, but did so on stiffer substrates, including TCPS. The GPa elastic modulus of TCPS does not recapitulate the modulus of the in vivo microenvironment presented to the VICs in a healthy or diseased valve, whereas the softer ≈6-kPa (E) poly(ethylene glycol) hydrogel and ≈20-kPa thick collagen gel better mimic the elasticity of native aortic valve tissue.
11 This work not only shows how altering the culture substrate elasticity can elicit different VIC responses (healthy versus pathological) but also underscores the need to transition away from the commonly used TCPS to culture platforms that allow for manipulation of the matrix elasticity to physiologically relevant levels to gain a better understanding of in vivo VIC biology. Kloxin et al 38 used poly(ethylene glycol) hydrogels of varying elasticities to gain more accurate insight into VIC biology. This work demonstrated that as culture substrate elastic modulus is increased, the percentage of myofibroblasts in the population is also significantly increased. In addition, a threshold for VIC activation (defined as ≥50% of the population being myofibroblasts) at a Young modulus of 15 kPa was identified.
In addition to VIC phenotype and nodule formation, the Anseth research group has studied the effects of cell culture substrate elasticity on VIC ECM protein expression. These studies used a poly(ethylene glycol)-based hydrogel platform of moduli more reminiscent of the healthy and diseased in vivo environment. 36 Gould et al 36 demonstrated that the fraction of collagen expressed was significantly reduced on softer gels of nonactivating moduli compared with stiffer activating gels and TCPS. A high level of collagen deposition is generally associated with disease progression of the valve to the sclerotic stage, where excess secretion of active matrix metalloproteinases degrades away the valve tissue, and it is replaced with rigid collagen fibers. 1, 18, 42 An important mode by which matrix elasticity influences VIC function is by modulating cell response to pathological biochemical cues. For example, TGF-β1-induced myofibroblast differentiation of VICs in vitro occurs only on substrates with elastic moduli that exceed ≈11 to 22 kPa. 11 This is possibly due, in part, to downregulation of TGF-β1 receptors on soft substrates, 40 but the Wnt/β-catenin pathway also plays a critical role because β-catenin nuclear translocation increases with increasing matrix stiffness, and silencing or degrading β-catenin abolishes TGF-β1-induced VIC myofibroblast differentiation. 11 The response of VICs to osteogenic biochemical factors is also modulated by matrix stiffness. Yip et al 40 found that VICs cultured in osteogenic media formed calcific nodules on both compliant and stiff collagen gels, but the characteristics of the formed nodules differed. On compliant substrates similar to native valve tissue elasticity, VICs readily formed many small aggregates of viable cells that expressed bone genes and proteins, putatively leading to osteogenic mineralization of the aggregates. However, when the VICs were cultured in osteogenic media on stiffer gels that mimicked the stiffness of stenotic tissue, the VICs activated to the myofibroblast phenotype and the calcific nodules formed were larger and sparser and contained apoptotic cells. Bone marker expression was minimal in this case, and calcification was dystrophic. Thus, biochemically induced osteogenic differentiation of VICs is favored on intermediate stiffness substrates (≈25 kPa), whereas myofibroblast differentiation and dystrophic calcification are favored on stiffer substrates. Notably, the threshold matrix stiffness for biochemically induced pathological differentiation of VICs only occurs in the fibrosa of normal aortic valves, perhaps explaining why fibrosis and calcification occur preferentially in this layer. 112 Consideration for the modulatory role of the matrix in VIC response to biochemical cues may also be instrumental in developing preventive treatments for calcific aortic valve disease.
Matricellular Effects on VIC Function
In addition to the matrix elasticity, cell-ECM protein interactions have an important role in regulating the function of VICs. Cushing et al 22 have demonstrated that various ECM proteins coated on TCPS (ie, cell-ECM protein interactions) can influence the amount of VIC αSMA expression. Fibronectin and collagen-1 significantly increased and decreased αSMA expression, respectively, compared with the uncoated TCPS control. The Masters research group has also studied dystrophic calcific nodule formation by VICs with varying cell-ECM protein interactions. 37 Whole ECM molecules (eg, fibronectin, collagen, laminin, or fibrin) and small peptides derived from the first 3 molecules (ie, RGDS, DGEA, and YIGSR, respectively) were coated on TCPS, and VIC nodule formation and calcium deposition were analyzed. Fibronectin, collagen, and laminin caused similar levels of nodule formation, but fibrin caused a very significant increase in calcific nodule formation. With regard to the integrin-binding small peptides, RGDS caused significantly more nodule formation than any of the other peptides. RGDS is generally associated with fibronectin, 113 but it is present in many biological microenvironments such as fibrin and the protective exterior of the latent TGF-β1 complex. 20 An important implication of these studies is that the interaction of VICs with collagen in the fibrosa layer of valve leaflets may help maintain homeostasis by protecting against myofibroblast activation. However, VICs were grown in TCPS under static conditions in these studies; improved insight into the role of ECM proteins in regulating VIC phenotype will require culture substrates with physiologically relevant elasticity and dynamic strain culture conditions. To that end, Moraes et al 108 stretched VICs on collagen-I and fibronectin using a microscale cell-stretching platform and measured myofibroblast differentiation. They found that myofibroblast differentiation by VICs in response to strain was indeed dependent on the ECM protein, with collagen being less myofibrogenic than fibronectin, particularly for VICs isolated from the fibrosa layer of the leaflet. Although their system did not allow control of substrate stiffness, others have integrated soft polymers onto stretching devices that could be used to investigate the combined effects of matrix elasticity, biochemistry, and dynamic stretch.
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Future of Hemodynamic Regulation of Calcific Aortic Valve Disease In Vitro Research
Very few current research endeavors include all of the discussed hemodynamic and matricellular aspects of the valve cell microenvironments, which are all apparently critical to proper aortic valve function in vivo. Understanding the complex interplay between all of the mechanobiological cues that influence valve homeostasis and disease progression is challenging in both in vivo animal models and in vitro standard tissue culture systems. An important step toward this end will be the development of enabling culture platforms and model systems that incorporate multiple, precisely controlled mechanical and biochemical cues. This culture platform may include a synthetic material platform of native or pathological elasticities, with relevant matricellular cues of interest incorporated. Culturing VICs and VlvECs in a more physiologically relevant manner is also a key aspect in discerning in vivo biological functions. Thus, cultures in 3 dimensions with VICs interspersed in the material and VlvECs lining the exterior will be of upmost importance. This type of 3-dimensional coculture of both valve cell types will allow greater control of the cellular microenvironment (eg, matrix elasticity) than the current whole-valve explantation studies while retaining the apparently crucial paracrine signaling interplay between VICs and VlvECs. However, hemodynamic cues to valve cells are a critical aspect of proper valve maintenance and function, as demonstrated by this review, and cannot be ignored. Thus, it is critical to culture cell-laden synthetic matrices or explanted tissues in a manner in which hemodynamic mechanical cues may be included. Bioreactors and advancement in their design provide one attractive method. Depending on the setup, bioreactors allow a multitude of different hemodynamic mechanical cues to be administered on the cultured cells, including shear stress, stretching, and, most interesting, native valve leaflet motion. Taken together, each of these culture aspects should allow a more physiologically relevant culture environment and thus a more accurate and global understanding of aortic valve biology and disease progression. With this increased level of understanding, new preventive and potentially reverting treatments may be envisioned and produced to treat calcific aortic valve disease.
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